The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tyrosine Kinase Inhibitors-Global Market Insights and Sales Trends 2024
Synopsis
Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.
The global Tyrosine Kinase Inhibitors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tyrosine Kinase Inhibitors in various end use industries. The expanding demands from the Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer and Renal Cell Cancer, are propelling Tyrosine Kinase Inhibitors market. BCR-ABL Tyrosine Kinase Inhibitor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tyrosine Kinase Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tyrosine Kinase Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tyrosine Kinase Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tyrosine Kinase Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tyrosine Kinase Inhibitors covered in this report include AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb, Bayer, Boehringer Ingelheim International, F. Hoffmann-La Roche, Johnson & Johnson and Eisai, etc.
The global Tyrosine Kinase Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Pfizer
Novartis
Bristol-Myers Squibb
Bayer
Boehringer Ingelheim International
F. Hoffmann-La Roche
Johnson & Johnson
Eisai
Global Tyrosine Kinase Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tyrosine Kinase Inhibitors market, Segment by Type:
BCR-ABL Tyrosine Kinase Inhibitor
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
Global Tyrosine Kinase Inhibitors market, by Application
Chronic Myeloid Leukemia (CML)
Lung Cancer
Breast Cancer
Renal Cell Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tyrosine Kinase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tyrosine Kinase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.
The global Tyrosine Kinase Inhibitors market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Tyrosine Kinase Inhibitors in various end use industries. The expanding demands from the Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer and Renal Cell Cancer, are propelling Tyrosine Kinase Inhibitors market. BCR-ABL Tyrosine Kinase Inhibitor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors segment is estimated at % CAGR for the next seven-year period.
The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tyrosine Kinase Inhibitors, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tyrosine Kinase Inhibitors market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tyrosine Kinase Inhibitors market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tyrosine Kinase Inhibitors sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tyrosine Kinase Inhibitors covered in this report include AstraZeneca, Pfizer, Novartis, Bristol-Myers Squibb, Bayer, Boehringer Ingelheim International, F. Hoffmann-La Roche, Johnson & Johnson and Eisai, etc.
The global Tyrosine Kinase Inhibitors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Pfizer
Novartis
Bristol-Myers Squibb
Bayer
Boehringer Ingelheim International
F. Hoffmann-La Roche
Johnson & Johnson
Eisai
Global Tyrosine Kinase Inhibitors market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tyrosine Kinase Inhibitors market, Segment by Type:
BCR-ABL Tyrosine Kinase Inhibitor
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
Global Tyrosine Kinase Inhibitors market, by Application
Chronic Myeloid Leukemia (CML)
Lung Cancer
Breast Cancer
Renal Cell Cancer
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tyrosine Kinase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tyrosine Kinase Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tyrosine Kinase Inhibitors Market Overview
1.1 Tyrosine Kinase Inhibitors Product Overview
1.2 Tyrosine Kinase Inhibitors Market Segment by Type
1.2.1 BCR-ABL Tyrosine Kinase Inhibitor
1.2.2 Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
1.2.3 Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
1.3 Global Tyrosine Kinase Inhibitors Market Size by Type
1.3.1 Global Tyrosine Kinase Inhibitors Market Size Overview by Type (2018-2029)
1.3.2 Global Tyrosine Kinase Inhibitors Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tyrosine Kinase Inhibitors Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tyrosine Kinase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tyrosine Kinase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tyrosine Kinase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tyrosine Kinase Inhibitors Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tyrosine Kinase Inhibitors Sales Breakdown by Type (2018-2023)
2 Global Tyrosine Kinase Inhibitors Market Competition by Company
2.1 Global Top Players by Tyrosine Kinase Inhibitors Sales (2018-2023)
2.2 Global Top Players by Tyrosine Kinase Inhibitors Revenue (2018-2023)
2.3 Global Top Players by Tyrosine Kinase Inhibitors Price (2018-2023)
2.4 Global Top Manufacturers Tyrosine Kinase Inhibitors Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tyrosine Kinase Inhibitors Market Competitive Situation and Trends
2.5.1 Tyrosine Kinase Inhibitors Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tyrosine Kinase Inhibitors Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tyrosine Kinase Inhibitors as of 2022)
2.7 Date of Key Manufacturers Enter into Tyrosine Kinase Inhibitors Market
2.8 Key Manufacturers Tyrosine Kinase Inhibitors Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tyrosine Kinase Inhibitors Status and Outlook by Region
3.1 Global Tyrosine Kinase Inhibitors Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tyrosine Kinase Inhibitors Historic Market Size by Region
3.2.1 Global Tyrosine Kinase Inhibitors Sales in Volume by Region (2018-2023)
3.2.2 Global Tyrosine Kinase Inhibitors Sales in Value by Region (2018-2023)
3.2.3 Global Tyrosine Kinase Inhibitors Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tyrosine Kinase Inhibitors Forecasted Market Size by Region
3.3.1 Global Tyrosine Kinase Inhibitors Sales in Volume by Region (2024-2029)
3.3.2 Global Tyrosine Kinase Inhibitors Sales in Value by Region (2024-2029)
3.3.3 Global Tyrosine Kinase Inhibitors Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tyrosine Kinase Inhibitors by Application
4.1 Tyrosine Kinase Inhibitors Market Segment by Application
4.1.1 Chronic Myeloid Leukemia (CML)
4.1.2 Lung Cancer
4.1.3 Breast Cancer
4.1.4 Renal Cell Cancer
4.1.5 Others
4.2 Global Tyrosine Kinase Inhibitors Market Size by Application
4.2.1 Global Tyrosine Kinase Inhibitors Market Size Overview by Application (2018-2029)
4.2.2 Global Tyrosine Kinase Inhibitors Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tyrosine Kinase Inhibitors Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tyrosine Kinase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tyrosine Kinase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tyrosine Kinase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tyrosine Kinase Inhibitors Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tyrosine Kinase Inhibitors Sales Breakdown by Application (2018-2023)
5 North America Tyrosine Kinase Inhibitors by Country
5.1 North America Tyrosine Kinase Inhibitors Historic Market Size by Country
5.1.1 North America Tyrosine Kinase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tyrosine Kinase Inhibitors Sales in Volume by Country (2018-2023)
5.1.3 North America Tyrosine Kinase Inhibitors Sales in Value by Country (2018-2023)
5.2 North America Tyrosine Kinase Inhibitors Forecasted Market Size by Country
5.2.1 North America Tyrosine Kinase Inhibitors Sales in Volume by Country (2024-2029)
5.2.2 North America Tyrosine Kinase Inhibitors Sales in Value by Country (2024-2029)
6 Europe Tyrosine Kinase Inhibitors by Country
6.1 Europe Tyrosine Kinase Inhibitors Historic Market Size by Country
6.1.1 Europe Tyrosine Kinase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tyrosine Kinase Inhibitors Sales in Volume by Country (2018-2023)
6.1.3 Europe Tyrosine Kinase Inhibitors Sales in Value by Country (2018-2023)
6.2 Europe Tyrosine Kinase Inhibitors Forecasted Market Size by Country
6.2.1 Europe Tyrosine Kinase Inhibitors Sales in Volume by Country (2024-2029)
6.2.2 Europe Tyrosine Kinase Inhibitors Sales in Value by Country (2024-2029)
7 Asia-Pacific Tyrosine Kinase Inhibitors by Region
7.1 Asia-Pacific Tyrosine Kinase Inhibitors Historic Market Size by Region
7.1.1 Asia-Pacific Tyrosine Kinase Inhibitors Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tyrosine Kinase Inhibitors Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tyrosine Kinase Inhibitors Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tyrosine Kinase Inhibitors Forecasted Market Size by Region
7.2.1 Asia-Pacific Tyrosine Kinase Inhibitors Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tyrosine Kinase Inhibitors Sales in Value by Region (2024-2029)
8 Latin America Tyrosine Kinase Inhibitors by Country
8.1 Latin America Tyrosine Kinase Inhibitors Historic Market Size by Country
8.1.1 Latin America Tyrosine Kinase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tyrosine Kinase Inhibitors Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tyrosine Kinase Inhibitors Sales in Value by Country (2018-2023)
8.2 Latin America Tyrosine Kinase Inhibitors Forecasted Market Size by Country
8.2.1 Latin America Tyrosine Kinase Inhibitors Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tyrosine Kinase Inhibitors Sales in Value by Country (2024-2029)
9 Middle East and Africa Tyrosine Kinase Inhibitors by Country
9.1 Middle East and Africa Tyrosine Kinase Inhibitors Historic Market Size by Country
9.1.1 Middle East and Africa Tyrosine Kinase Inhibitors Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tyrosine Kinase Inhibitors Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tyrosine Kinase Inhibitors Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tyrosine Kinase Inhibitors Forecasted Market Size by Country
9.2.1 Middle East and Africa Tyrosine Kinase Inhibitors Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tyrosine Kinase Inhibitors Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Tyrosine Kinase Inhibitors Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Tyrosine Kinase Inhibitors Products Offered
10.2.5 Pfizer Recent Development
10.3 Novartis
10.3.1 Novartis Company Information
10.3.2 Novartis Introduction and Business Overview
10.3.3 Novartis Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis Tyrosine Kinase Inhibitors Products Offered
10.3.5 Novartis Recent Development
10.4 Bristol-Myers Squibb
10.4.1 Bristol-Myers Squibb Company Information
10.4.2 Bristol-Myers Squibb Introduction and Business Overview
10.4.3 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bristol-Myers Squibb Tyrosine Kinase Inhibitors Products Offered
10.4.5 Bristol-Myers Squibb Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Tyrosine Kinase Inhibitors Products Offered
10.5.5 Bayer Recent Development
10.6 Boehringer Ingelheim International
10.6.1 Boehringer Ingelheim International Company Information
10.6.2 Boehringer Ingelheim International Introduction and Business Overview
10.6.3 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boehringer Ingelheim International Tyrosine Kinase Inhibitors Products Offered
10.6.5 Boehringer Ingelheim International Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Information
10.7.2 F. Hoffmann-La Roche Introduction and Business Overview
10.7.3 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.7.4 F. Hoffmann-La Roche Tyrosine Kinase Inhibitors Products Offered
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Tyrosine Kinase Inhibitors Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Eisai
10.9.1 Eisai Company Information
10.9.2 Eisai Introduction and Business Overview
10.9.3 Eisai Tyrosine Kinase Inhibitors Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Eisai Tyrosine Kinase Inhibitors Products Offered
10.9.5 Eisai Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tyrosine Kinase Inhibitors Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tyrosine Kinase Inhibitors Industrial Chain Analysis
11.4 Tyrosine Kinase Inhibitors Market Dynamics
11.4.1 Tyrosine Kinase Inhibitors Industry Trends
11.4.2 Tyrosine Kinase Inhibitors Market Drivers
11.4.3 Tyrosine Kinase Inhibitors Market Challenges
11.4.4 Tyrosine Kinase Inhibitors Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tyrosine Kinase Inhibitors Distributors
12.3 Tyrosine Kinase Inhibitors Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
